Check out this interactive activity to obtain education on the treatment of chronic spontaneous urticaria (CSU) that is tailored specifically for you! As you answer questions, customized educational pathways will supply you with real-time feedback and resources targeted to your level of knowledge and comprehension. This curated information will feature key inflammatory pathways involved in the development of CSU, recent data for emerging therapies that target these pathways, and the latest guidelines for the treatment of CSU. Throughout, patients will share their real-life experiences with the management of this debilitating condition. This activity is delivered in partnership with the Allergy & Asthma Network.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/exploring-latest-evidence-guidelines-treatment-chronic-spontaneous-urticaria
- Start Date: 2024-04-26 05:00:00
- End Date: 2024-04-26 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: Novartis Corporation Pharmaceuticals - Amount: 79750.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest